New! Sign up for our free email newsletter.
Science News
from research organizations

Adderall misuse rising among young adults

Prescriptions for the stimulant unchanged, but study finds more nonmedical use and emergency room visits among adults

Date:
February 16, 2016
Source:
Johns Hopkins University Bloomberg School of Public Health
Summary:
While the number of prescriptions for the stimulant Adderall has remained unchanged among young adults, misuse and emergency room visits related to the drug have risen dramatically in this group, new research suggests.
Share:
FULL STORY

While the number of prescriptions for the stimulant Adderall has remained unchanged among young adults, misuse and emergency room visits related to the drug have risen dramatically in this group, new Johns Hopkins Bloomberg School of Public Health research suggests.

Anecdotal evidence had suggested the most severe problem of Adderall misuse was among older children and adolescents, but the new research -- published Feb. 16 in The Journal of Clinical Psychiatry -- finds otherwise. The study examined trends from 2006 through 2011 and found that it is mainly 18-to-25-year-olds who are inappropriately taking Adderall without a prescription, primarily getting the medication from family and friends and without a physician recommendation or prescription.

"The growing problem is among young adults," says study co-author Ramin Mojtabai, MD, MPH, PhD, a professor of mental health at the Bloomberg School. "In college, especially, these drugs are used as study-aid medication to help students stay up all night and cram. Our sense is that a sizeable proportion of those who use them believe these medications make them smarter and more capable of studying. We need to educate this group that there could be serious adverse effects from taking these drugs and we don't know much at all about their long-term health effects."

Says first author Lian-Yu Chen, MD, who received her PhD in 2014 from the Bloomberg School: "The number of prescriptions for Adderall has fallen and yet we are seeing more medical problems from its use. This suggests that the main driver of misuse and emergency room visits related to the drug is the result of diversion, people taking medication that is legitimately prescribed to someone else. Physicians need to be much more aware of what is happening and take steps to prevent it from continuing."

Adderall, the brand name for dextroamphetamine-amphetamine, does improve focus, Mojtabai says, but it can also cause sleep disruption and serious cardiovascular side effects, such as high blood pressure and stroke. It also increases the risk for mental health problems, including depression, bipolar disorder and unusual behaviors including aggressive or hostile behavior. There is little research on long-term effects. In 2006, the Food and Drug Administration (FDA) put a black box warning on dextroamphetamine-amphetamine due to cardiovascular risks. It is prescribed for conditions such as attention deficit/hyperactivity disorder and narcolepsy.

For their study, the researchers examined three separate sets of data: the National Survey on Drug Use and Health, a population survey of substance use; the Drug Abuse Warning Network, a survey of emergency department visits; and the National Disease and Therapeutic Index, a survey of office-based practices including prescribing.

They found that in adults, over the six-year study period, treatment visits involving Adderall were unchanged, while non-medical use of Adderall (that is, taking the drug without it being prescribed) rose 67 percent and emergency room visits went up 156 percent. Over the same period, in adolescents, treatment visits involving Adderall went down, nonmedical use was stable and emergency room visits declined by 54 percent. The trends for methylphenidate, sold under the brand name Ritalin among others, and another prescription stimulant prescribed for attention-deficit/hyperactivity disorder, were unchanged over the period.

Meanwhile, the major source for nonmedical use of Adderall was family or friends; two-thirds of those family or friends obtained it by prescription.

The researchers found that of all Adderall nonmedical use, from age 12 and up, 60 percent of it was among 18-to-25-year-olds.

Mojtabai says that from a public health perspective, drugs like Adderall should be monitored in the same way that prescription painkillers have started to be monitored in recent years. He says prescriptions should be entered into a database that a physician could check before writing a prescription to make sure the patient isn't receiving multiple medications from multiple physicians, a warning sign of diversion or abuse.

He also says it would be helpful to institute informational campaigns for young adults explaining the adverse effects associated with the drug. "Many of these college students think stimulants like Adderall are harmless study aids," he says. "But there can be serious health risks and they need to be more aware."


Story Source:

Materials provided by Johns Hopkins University Bloomberg School of Public Health. Note: Content may be edited for style and length.


Journal Reference:

  1. Elle M. Sowa, MD; Jonathan C. Fellers, MD; Rachna S. Raisinghani, MBBS; Maria R. Santa Cruz, MD; Priscilla C. Hidalgo, MD; Meredith S. Lee, DO; Lady A. Martinez, MD; Adrienne E. Keller, PhD; and Anita H. Clayton, MD. Prescriptions, Nonmedical Use, and Emergency Department Visits Involving Prescription Stimulants. Journal of Clinical Psychiatry, February 2016

Cite This Page:

Johns Hopkins University Bloomberg School of Public Health. "Adderall misuse rising among young adults." ScienceDaily. ScienceDaily, 16 February 2016. <www.sciencedaily.com/releases/2016/02/160216142831.htm>.
Johns Hopkins University Bloomberg School of Public Health. (2016, February 16). Adderall misuse rising among young adults. ScienceDaily. Retrieved November 22, 2024 from www.sciencedaily.com/releases/2016/02/160216142831.htm
Johns Hopkins University Bloomberg School of Public Health. "Adderall misuse rising among young adults." ScienceDaily. www.sciencedaily.com/releases/2016/02/160216142831.htm (accessed November 22, 2024).

Explore More

from ScienceDaily

RELATED STORIES